A Phase II Study of Modified FOLFOX4 for Colorectal Cancer Patients with Peritoneal Carcinomatosis
Dong Hyun Lee, Sung Yong Oh, Yu Rim Lee, Seok Jae Huh, Hyun Hwa Yoon, Sung Hyun Kim, Suee Lee, Ji Hyun Lee, Young Kim, Hyo-Jin Kim, Hyuk-Chan Kwon
Cancer Res Treat. 2011;43(4):225-230.   Published online 2011 Dec 27     DOI: https://doi.org/10.4143/crt.2011.43.4.225
Citations to this article as recorded by Crossref logo
Perioperative Systemic Chemotherapy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: Results of the Prospective Multicenter Phase 2 COMBATAC Trial
Gabriel Glockzin, Florian Zeman, Roland S. Croner, Alfred Königsrainer, Jörg Pelz, Michael A. Ströhlein, Beate Rau, Dirk Arnold, Michael Koller, Hans J. Schlitt, Pompiliu Piso
Clinical Colorectal Cancer.2018; 17(4): 285.     CrossRef
Treatment of peritoneal metastases from small bowel adenocarcinoma
Koen P. Rovers, Eelco de Bree, Yutaka Yonemura, Ignace H. de Hingh
International Journal of Hyperthermia.2017; 33(5): 571.     CrossRef
Percutaneous lung ablation of pulmonary recurrence may improve survival in selected patients undergoing cytoreductive surgery for colorectal cancer with peritoneal carcinomatosis
T.A. Bin Traiki, O.M. Fisher, S.J. Valle, R.N. Parikh, M.A. Kozman, D. Glenn, M. Power, W. Liauw, N.A. Alzahrani, D.L. Morris
European Journal of Surgical Oncology (EJSO).2017; 43(10): 1939.     CrossRef
Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis
C. Demtröder, W. Solass, J. Zieren, D. Strumberg, U. Giger-Pabst, M.-A. Reymond
Colorectal Disease.2016; 18(4): 364.     CrossRef
Therapeutic options for peritoneal metastasis arising from colorectal cancer
Gabriel Glockzin, Hans J Schlitt, Pompiliu Piso
World Journal of Gastrointestinal Pharmacology and Therapeutics.2016; 7(3): 343.     CrossRef
Challenges in the multidisciplinary management of stage IV colon and rectal cancer
Pompiliu Piso, Dirk Arnold, Gabriel Glockzin
Expert Review of Gastroenterology & Hepatology.2015; 9(3): 317.     CrossRef
Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis
Gabriel Glockzin, Michael Gerken, Sven A Lang, Monika Klinkhammer-Schalke, Pompiliu Piso, Hans J Schlitt
BMC Cancer.2014;[Epub]     CrossRef
Should isolated peritoneal carcinomatosis from colorectal cancer be sub-classified into stage IVB in era of modern chemotherapy?
H. Ishida, K. Kumamoto, K. Ishibashi, S. Hatano, T. Matsuzawa, N. Okada, Y. Kumagai, H. Baba, N. Haga
Techniques in Coloproctology.2013; 17(6): 647.     CrossRef
Peritoneal carcinomatosis of colorectal origin: is it really an end-stage disease?
E. Chouillard, V. Greco, N. Tsiminikakis
Techniques in Coloproctology.2013; 17(6): 619.     CrossRef
Peritoneal carcinomatosis from colorectal cancer: hyperthermic intraperitoneal chemotherapy and the role of systemic chemotherapy
Michael Michael
Colorectal Cancer.2013; 2(5): 449.     CrossRef
Role of Chemotherapy in Peritoneal Carcinomatosis in Metastatic Colorectal Cancer
Jan Franko, Charles D. Goldman, Kiran K. Turaga
Current Colorectal Cancer Reports.2013; 9(3): 242.     CrossRef
A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial
Gabriel Glockzin, Justine Rochon, Dirk Arnold, Sven A Lang, Frank Klebl, Florian Zeman, Michael Koller, Hans J Schlitt, Pompiliu Piso
BMC Cancer.2013;[Epub]     CrossRef